hrp0098fc8.1 | Adrenals and HPA Axis 2 | ESPE2024

Quantitative proteomics of pediatric adrenocortical tumors provides insights into zone of origin and identifies overrepresented pathways

Metousis Andreas , E. Fincke Victoria , A. Wudy Stefan , Jüttner Eva , Kunstreich Marina , D. Johann Pascal , Redlich Antje , Schweizer Lisa , Claus Rainer , Mann Matthias , Kuhlen Michaela

Introduction: Pediatric adrenocortical tumors (pACT), comprising highly malignant pediatric adrenocortical carcinomas (pACCs) and less aggressive adenomas (pACAs), present a rare yet clinically significant challenge. pACTs often pose a diagnostic and therapeutic dilemma due to their elusive differentiation and resistance to therapy. Originating from the adrenal cortex, pACTs are functional and, thus, characterized by a unique urinary steroid metabolome. This s...

hrp0084p3-902 | Fat | ESPE2015

Identification and Management of Obesity by General Paediatricians in the UK

Easwariah Madhu , Mann Jake , Goonetilleke Rajiv

Background: A third of children in the UK are obese or overweight. The majority are not in contact with medical services. Presentation to general paediatricians for unrelated condition may pose an opportunity to identify children with obesity. The UK obesity services for Children & Adolescents (OSCA) group have produced guidelines for management of obese children in secondary care.Objective and hypotheses: Determine the prevalence of obesity in gener...

hrp0098p2-356 | Late Breaking | ESPE2024

Severe oedema during treatment with long acting GH

Börschel-Thomsen Matthias , Simic-Schleicher Gunter

A 15 year old girl presented with severe symptomatic hypoglycaemia. Diagnostic work up revealed only a diminished GH secretion at and during severe hypoglycaemia and after arginine stimulation. Injection of GH twice daily abolished the hypoglycaemia for several days. For practicability a treatment with long acting GH (Ngenla) 46 mg/week was started. Symptoms were not entirely abolished, so that the dose was increased to 54 mg /week which was successful. However 2 weeks after t...

hrp0097p1-344 | Pituitary, Neuroendocrinology and Puberty | ESPE2023

Neurobehavioural impairments in children with septo-optic dysplasia spectrum conditions: A systematic review

Mann Amy , Aghababaie Arameh , Kalitsi Jennifer , Martins Daniel , Paloyelis Yannis , R Kapoor Ritika

Background: Septo-optic dysplasia (SOD) is a rare condition diagnosed in children with two or more of the following: hypopituitarism, midline brain abnormalities, and optic nerve hypoplasia (ONH). Children with SOD experience varied visual impairment and endocrine dysfunction. Autistic-like behaviours have been reported, however the nature and prevalence of these neurobehavioural impairments remain to be fully understood. The present systematic review aimed to...

hrp0098p2-5 | Adrenals and HPA Axis | ESPE2024

Pharmacological therapy of adrenal hypercortisolism in a boy with suspected isolated micronodular adrenal hyperplasia (iMAD) due to a mutation in the PDE11A gene

Marx Michaela , F. Gaßmann Katja , Tzschoppe Anja , Nurcan Cebeci Ayse , Woelfle Joachim

Background: iMAD is a very rare cause of ACTH-independent Cushing´s syndrome in young children. Bilateral adrenalectomy is a definitive treatment, but poses young children at a high risk due to life-long adrenal insufficiency. Therefore, pharmacological treatment with metyrapone seems an alternative bridging option for a limited period of time.Case report: A 3 6/12 year old boy presented with a history of rapid wei...

hrp0084wg4.2 | Obesity | ESPE2015

A Monomeric Peptide Triagonist for the Treatment of Obesity and Diabetes

Clemmensen Christoffer , Finan Brian , Muller Timo , DiMarchi Richard , Tschop Matthias

Encouraged by unimolecular dual incretin co-agonists (GLP1/GIP) to enhance glycemic efficacy (Finan et al. 2013, Sci Transl Med) and GLP1/glucagon co-agonists to enhance weight loss efficacy (Day et al. 2009, Nat Chem Biol) and to restore diet-induced leptin sensitivity (Clemmensen et al. 2014, Diabetes), we recently developed the first tri-agonist (GLP1/GIP/glucagon) for the treatment of metabolic disorders (Finan et al. 2014, Nat Med). Importantly, this concerted triple agon...

hrp0098p2-152 | GH and IGFs | ESPE2024

Successful Treatment of increasing chronic Hypoglycaemia by long acting GH a 15y old girl with reduced GH Secretion

Börschel-Thomsen Matthias , Kunath Isabel , Simic-Schleicher Gunter

A 15y old girl presented with severe hypoglycaemic symptoms in combination with low blood glucose levels (<60 mg/dl). She had symptoms for over 1 year in combination with reduced activity, development of oligomenorrhoea after 2 years of normal cycles, increased fluid intake. Continuous sc. glucose measurement revealed constantly low or reduced glucose levels apart from a few increases after meals. Metabolic laboratory testing was normal apart from a single diminished GH lev...

hrp0097p1-556 | Pituitary, Neuroendocrinology and Puberty | ESPE2023

Oxytocin Improved Neurobehavioural Dysfunction in an Adolescent Post-Craniopharyngioma Surgery: A case report

Mann Amy , Fox Krystal , Kalitsi Jennifer , R Buchanan Charles , Bhushan Arya Ved , Paloyelis Yannis , R Kapoor Ritika

Background: Craniopharyngioma is a benign tumour that develops in the sellar and surrounding parasellar regions, including the hypothalamus and the pituitary gland responsible for the production and regulation of neuropeptides. Oxytocin is a hypothalamic neuropeptide that has been identified as a key modulator of appetite drive and social cognition. Here, we present a case of parent-observed improvements in neurobehavioural dysfunction following administration...

hrp0082p2-d3-498 | Endocrine Oncology | ESPE2014

A Rare Brain Tumor in Noonan Syndrome: Report of Two Cases

Pellegrin Maria Chiara , Tornese Gianluca , Cattaruzzi Elisabetta , Blank Eva , Kieslich Matthias , Ventura Alessandro

Background: Noonan syndrome (NS) is a congenital polymalformative disorder caused by aberrant up-regulated signalling through RAS GTPase. Although NS is associated with hematologic malignancies, no predisposition for neuronal tumors was reported so far.Objective and hypotheses: We describe two cases of young patients with NS and dysembryoplastic neuroepithelial tumor (DNET). This is the first case series reporting a rare type of intracranial tumor in NS....

hrp0084p2-453 | Growth | ESPE2015

Cross-Sectional and Longitudinal Follow-Up of Changes in Glucose Metabolism in Prepubertal GH-Treated SGA-Patients: Results of an Unicentric Study

Sydlik Carmen , Bechtold Susanne , Weissenbacher Claudia , Roeb Julia , Buckl Matthias , Putzker Stefanie , Schmidt Heinrich

Background: Several studies show impaired glucose tolerance at a certain number of years after start of growth hormone in SGA-children.Objective and hypotheses: To perform a longitudinal and cross-sectional evaluation of the oGTTs (glucose-insulin-pairs) in prepubertal GH-treated SGA-children and to evaluate if ISI and HOMA are effective surrogates for glucose tolerance and of prognostic value (0–1 year data).Method: In 81 pre...